| Ms Jennifer Sheridan, FNP-C | |
|
2139 Winchester Rd Ne, Huntsville, AL 35811-9803 | |
| (256) 489-9015 | |
| Not Available |
| Full Name | Ms Jennifer Sheridan |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 2139 Winchester Rd Ne, Huntsville, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730947250 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 1-172258 (Alabama) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 1-172258 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Jennifer Sheridan, FNP-C 2139 Winchester Rd Ne, Huntsville, AL 35811-9803 Ph: (256) 489-9015 | Ms Jennifer Sheridan, FNP-C 2139 Winchester Rd Ne, Huntsville, AL 35811-9803 Ph: (256) 489-9015 |
News Archive
Inspire Medical Systems, the leading developer of neurostimulation therapies for the treatment of obstructive sleep apnea (OSA), announced today The STAR trial, evaluating both the safety and effectiveness of Inspire Upper Airway Stimulation (UAS) therapy, is currently underway at 9 leading medical centers across the United States and at 4 sites in Europe.
The first licensed vaccine for the potentially life-threatening dengue virus should only be used in moderate-to high impacted regions, new research has predicted.
Adocia announces today positive preliminary results for the first clinical trial on an innovative formulation combining insulin analog Glargine (Lantus, Sanofi), the gold standard basal insulin, with a rapid-acting insulin analog, Lispro (Humalog, Eli Lilly) using Adocia's BioChaperone technology.
Weighing oneself has become one of the most common morning rituals. However, your weight is not the only message that can be delivered by your bathroom scales: the team of researchers at Kaunas University of Technology Institute of Biomedical Engineering are developing the multifunctional scales, which can monitor your health and inform about potentially dangerous life conditions, such as arteriosclerosis or cardiac arrhythmia.
Approval has been granted by the FDA for a gene-based test that helps tell early-stage breast cancer patients whether they need chemotherapy after their surgery.
› Verified 8 days ago